Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce W Robinson

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Blood-based early detection of malignant mesotheliomaEun-Kee Park, Paul S Thomas, Jenette Creaney, et al.
Clinical Chemistry and Laboratory Medicine|March 30, 2010
Factors affecting soluble mesothelin related protein levels in an asbestos-exposed populationEun-Kee Park, Paul S Thomas, Jenette Creaney, et al.
Safety and Health at Work|September 7, 2012
Association of biomarker levels with severity of asbestos-related diseasesEun-Kee Park, Deborah H Yates, Jenette Creaney, et al.
BMC Cancer|October 18, 2017
A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in miceWayne J Aston, Danika E Hope, Anna K Nowak, et al.
Disease Markers|December 16, 2014
Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesotheliomaJenette Creaney, Amanda Segal, Nola Olsen, et al.
American Journal of Respiratory and Critical Care Medicine|June 28, 2008
Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort studyEun-Kee Park, Alessandra Sandrini, Deborah H Yates, et al.
Carcinogenesis|October 17, 2013
Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistanceAmanda L Cleaver, Kasia Bhamidipaty, Ben Wylie, et al.
Biochemical and Biophysical Research Communications|January 28, 2019
Inhibition of collagen production delays malignant mesothelioma tumor growth in a murine modelKeith S Abayasiriwardana, Michael K Wood, Cecilia M Prêle, et al.
Plos One|April 30, 2013
Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunityW Joost Lesterhuis, Joanne Salmons, Anna K Nowak, et al.
Scientific Reports|July 22, 2015
Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinationsW Joost Lesterhuis, Catherine Rinaldi, Anya Jones, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Blood-based early detection of malignant mesotheliomaEun-Kee Park, Paul S Thomas, Jenette Creaney, et al.
Clinical Chemistry and Laboratory Medicine|March 30, 2010
Factors affecting soluble mesothelin related protein levels in an asbestos-exposed populationEun-Kee Park, Paul S Thomas, Jenette Creaney, et al.
Safety and Health at Work|September 7, 2012
Association of biomarker levels with severity of asbestos-related diseasesEun-Kee Park, Deborah H Yates, Jenette Creaney, et al.
BMC Cancer|October 18, 2017
A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in miceWayne J Aston, Danika E Hope, Anna K Nowak, et al.
Disease Markers|December 16, 2014
Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesotheliomaJenette Creaney, Amanda Segal, Nola Olsen, et al.
American Journal of Respiratory and Critical Care Medicine|June 28, 2008
Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort studyEun-Kee Park, Alessandra Sandrini, Deborah H Yates, et al.
Carcinogenesis|October 17, 2013
Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistanceAmanda L Cleaver, Kasia Bhamidipaty, Ben Wylie, et al.
Biochemical and Biophysical Research Communications|January 28, 2019
Inhibition of collagen production delays malignant mesothelioma tumor growth in a murine modelKeith S Abayasiriwardana, Michael K Wood, Cecilia M Prêle, et al.
Plos One|April 30, 2013
Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunityW Joost Lesterhuis, Joanne Salmons, Anna K Nowak, et al.
Scientific Reports|July 22, 2015
Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinationsW Joost Lesterhuis, Catherine Rinaldi, Anya Jones, et al.
Pageof 4